SC 13G

Company

ADC Therapeutics SA

Filed

May 3, 2024

Accession Number

0001140361-24-024395

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →